Updated Drug Shortage Information for January 6, 2025

Jan 062025
 

New Shortages January 6, 2025 Adalimumab-adbm Injection (Discontinuation) Cisatracurium Besylate Injection (Discontinuation) Ezetimibe; Simvastatin Tablet (Discontinuation) Shortage Updates January 6, 2025 Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate,

Updated Drug Shortage Information for January 3, 2025

Jan 032025
 

New Shortages January 3, 2025 Lisdexamfetamine Dimesylate Capsule (Currently In Shortage) Shortage Updates January 3, 2025 Heparin Sodium Injection (Currently In Shortage) Hydromorphone Hydrochloride Injection (Currently In Shortage)

Updated Drug Shortage Information for January 2, 2025

Jan 022025
 

Shortage updates January 2, 2025 Fentanyl Citrate Injection (Currently In Shortage) Heparin Sodium Injection (Currently In Shortage) Hydromorphone Hydrochloride Injection (Currently In Shortage)

FDA Novel Drug Approvals – December 2024

Jan 012025
 

Drug Name Active Ingredient(s) Approval Date FDA-Approved Use on Approval Date Press Release Drug Trials Snapshot Alhemo concizumab-mtci 12/20/2024 For routine prophylaxis to prevent bleeding

FDA Drug Safety Information for December 24, 2024

Dec 242024
 

Date Brand Name(s) Description Type Reason Company  12/24/2024 Astellas Tacrolimus and Tacrolimus Extended-Release capsules Drugs Bottles may contain empty capsules. Astellas Pharma US, Inc.

FDA Drug Safety Information for December 20, 2024

Dec 202024
 

Date Brand Name(s) Description Type Reason Company  12/20/2024 Par Pharmaceutical Adrenalin® Chloride Solution (EPINEPHrine nasal solution, USP) Drugs Product is an unapproved drug. Endo, Inc.

 Older Entries  Newer Entries